Nov 21 (Reuters) - Dimerix Ltd DXB.AX :
* EUROPEAN COMMISSION HAS DESIGNATED DMX-200 AS AN ORPHAN MEDICINAL PRODUCT FOR TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Nov 21 (Reuters) - Dimerix Ltd DXB.AX :
* EUROPEAN COMMISSION HAS DESIGNATED DMX-200 AS AN ORPHAN MEDICINAL PRODUCT FOR TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS